Latest
Opinion & Analysis
Meet the Fundie
More From Today
This short seller is scooping up ASX stocks amid the mayhem
Blackwattle hedge fund manager Ray David has been snapping up cheap companies after US President Donald Trump unleashed a wave of new tariffs last week.
Yesterday
Nightmare on Wall Street leaves traders questioning hopes and fears
Some investors see method in the madness, others only madness. Here are the long-term and short-term risks, and opportunities, in Donald Trump’s new world.
Time to go back to the basics and buy stocks like these
We, like almost every other investor on the planet, underestimated Trump’s resolve to reshape global trade and just how far he appears willing to go to do this.
This Month
Trump’s trade ructions will end up disrupting banking and payments
European Central Bank president Christine Lagarde has lamented an almost exclusively American financial infrastructure. Others feel the same way.
Trump isn’t kowtowing to the market – he’s doubling down
Investors need to be bold during these dark days. You want to be buying when the crowd is throwing the baby out with the bathwater.
ASX sinks; Obesity is costing a fortune; Trump has no cunning plan
Read everything that’s happened in the news so far today.
A ‘classic emerging market crisis’ as investors flee US assets
The usual flight to safety toward long-term US government bonds occurred at first but has since very much reversed. The reversal shows no signs of slowing.
Calm descends on bond markets, but tariff war will push yields higher
Bond yields dropped after Trump stunned the market by pausing most of his reciprocal tariffs, but analysts warn that US Treasuries face higher borrowing costs still.
ASX adds $100b in best day since 2020; CBA up 3pc
Shares up 4.5pc after S&P500 jumps by most since 2008; US futures dip; miners, banks soar; Deutsche tips 25bps May rate cut; oil reverses course, $A tops US61¢.
Hedge fund manager John Hempton’s shorts pay off after horror months
Bronte Capital’s latest quarterly performance has delivered some reprieve for investors after Hempton put his struggling short-selling strategy under review late last year.
Traders brace for months of pain despite $100 billion relief rally
Oaktree’s Howard Marks said it was impossible to know where the Trump administration would take its tariff plans, even as their delay sent the ASX 200 soaring.
Why this fundie has doubled down on Pro Medicus
Naos Asset Management’s Robert Miller says the ASX listed medical imaging company is well worth its $204 price tag and talks volatility over the past few days.
ASX gains $112b; Why Trump backed down; Did he manipulate market?
Read everything that’s happened in the news so far today.
Five circuit breaks that can stop the market turmoil
Trade negotiations, central bank action and government stimulus are among the options being discussed by economists and strategists that would restore calm to financial markets.
Bond rout shakes investors as world’s safe haven loses its appeal
The turmoil in US government bonds overshadowed deep losses on the sharemarket, as traders were left wondering if this was “the end of exorbitant privilege”.
Revealed: RBA’s scathing warning it has ‘lost confidence’ in ASX
In a strongly worded missive sent to the exchange’s chief executive Helen Lofthouse weeks before an outage, the central bank warned of entrenched problems.
$A tipped to keep tumbling as superpowers ‘collide’
The Australian dollar hit a fresh five-year low below US60¢ and traders ramped up bets the RBA will slash the cash rate next month as fears of a global recession grow.
‘Huge’ profit downgrade cycle bears down on Wall Street
Analysts have barely budged their earnings forecasts for the world’s most important sharemarket despite recession alarms blaring, leaving equities vulnerable to a big reality check.
ASX wipes over $40b, bonds dive after US imposes jumbo China tariff
Shares drop 1.8pc at the closing bell after US imposes 104pc China tariff; Treasuries sell-off; RBNZ cuts rates by 25bps; oil, iron ore sink; Regal’s $540m Opthea blow.
ASX wipes $32b; Tariffs to hit pharma; $1.3trn trade unwinds
Read everything that’s happened in the news so far today.